Jenny Petersen

Director, Clinical Trial Disclosure and Transparency at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jenny Petersen's Colleagues at Alnylam Pharmaceuticals
Jason Crommett

Quality Assurance Specialist

Contact Jason Crommett

Nate Jaffer

Senior Manager, Artwork Management

Contact Nate Jaffer

Mark Keibler

Scientist, Research & Development

Contact Mark Keibler

Chelsea Tyler

Patient Services Operations Specialist

Contact Chelsea Tyler

Matt White

Director, Biostatistics

Contact Matt White

Mike Goodwin

Senior Facilities Manager

Contact Mike Goodwin

View All Jenny Petersen's Colleagues
Jenny Petersen's Contact Details
HQ
(617) 551-8200
Location
Greater Boston
Company
Alnylam Pharmaceuticals
Jenny Petersen's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jenny Petersen
Jenny Petersen currently works for Alnylam Pharmaceuticals.
Jenny Petersen's role at Alnylam Pharmaceuticals is Director, Clinical Trial Disclosure and Transparency.
Jenny Petersen's email address is ***@alnylam.com. To view Jenny Petersen's full email address, please signup to ConnectPlex.
Jenny Petersen works in the SaaS industry.
Jenny Petersen's colleagues at Alnylam Pharmaceuticals are Jason Crommett, Nate Jaffer, Mark Keibler, Chelsea Tyler, Matt White, Mitchell Menard, Mike Goodwin and others.
Jenny Petersen's phone number is (617) 551-8200
See more information about Jenny Petersen